Table 1.
Patient demographics and clinicopathologic characteristics of the 244 bile juice samples in our study
Age | mean | sd | ||||
68.5 | 11.8 | (yo) | ||||
Observation period | 37.3 | 24.8 | (month) | |||
ASA Score | 2.1 | 0.9 | ||||
Female | Male | |||||
Sex (n) | 90 | 154 | ||||
positive | negative | |||||
Chemotherapy (n) | 46 | 195 | ||||
BDAC | PDAC | GDAC | Panc. Cystic | benign | other | |
type (n) | 99 | 77 | 12 | 27 | 15 | 14 |
Bile Duct | Pancras | Gallbladder | other | |||
posision (n) | 101 | 112 | 17 | 14 | ||
(n) | (n) | (n) | ||||
Panc Cystic lesion | IPMC | 10 | IPMN | 20 | NET | 7 |
benign | (n) | |||||
Bile duct | Chronic cholangitis | 2 | ||||
Gallbladder | Chronic cholecystitis | 3 | ||||
Periampullary duodenal diverticulitis | 1 | |||||
gallstone | 1 | |||||
Pancreas | Mucinous cystadenoma | 1 | ||||
Chronic pancreatitis | 2 | |||||
Serous cystadenoma | 3 | |||||
Solid-pseudopapillary neoplasm | 2 | |||||
other | Diffuse large B cell lymphoma, GCB type | 1 | ||||
gastrointestinal stromal tumor | 5 | |||||
Low grade tublar adenoma | 1 | |||||
Metastasis of adenocarcinoma | 2 | |||||
Tubular adenocarcinoma | 3 | |||||
Tubular adenocarcinoma, well differentiated | 2 |
SD Standard deviation, ASA American Society of Anaesthesiologists, BDAC Cholangiocarcinoma, PDAC Pancreatic ductal adenocarcinoma, GDAC Gallbladder cancer, Panc. cystic Pancreas cystic lesion, IPMC Intraductal papillary mucinous carcinoma, IPMN Intraductal papillary mucinous neoplasm